Peter Jenkins is a Guarantors of Brain funded Clinical Fellow. He has a BMBCh from Oxford University and a Double First in Natural Sciences from Cambridge University.
The aims of his research are to investigate the role of dopamine dysregulation in traumatic brain injury and how this affects cognition.
et al., 2020, Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson’s disease, Journal of Neurology, Neurosurgery and Psychiatry, Vol:91, ISSN:0022-3050, Pages:631-637
et al., 2019, Stratifying drug treatment of cognitive impairments after traumatic brain injury using neuroimaging, Brain, Vol:142, ISSN:1460-2156, Pages:2367-2379
et al., 2018, Dopaminergic abnormalities following traumatic brain injury, Brain, Vol:141, ISSN:1460-2156, Pages:797-810
et al., 2017, Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration, Brain, Vol:141, ISSN:1460-2156, Pages:459-471
et al., 2017, Altered caudate connectivity is associated with executive dysfunction after traumatic brain injury, Brain, Vol:141, ISSN:1460-2156, Pages:148-164